Abstract
Recent regulatory and policy changes may help to improve the affordability of some high-cost cancer treatments. However, larger systemic changes are needed to address the excessive growth in spending for cancer therapies and to ensure that patients and payers receive maximum value for their health care dollars.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
